Effects of chemical manipulation of mitotic arrest and slippage on cancer cell survival and proliferation

Cell Cycle

Volumn 8, Issue 18, 2009, Pages 3029-3042

  Riffell, Jenna L ^a   Zimmerman, Carla ^a   Khong, Anthony ^a   McHardy, Lianne M ^a   Roberge, Michel ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Microtubule targeting agent; Mitosis; Mitotic arrest; Mitotic slippage; Paclitaxel

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; AGENTS AFFECTING CELL DIVISION; AKLAVIN; CGP 74514A; CHLORPROMAZINE; CYSTEINE DERIVATIVE; FISETIN; GERALDOL; PACLITAXEL; S TRITYLCYSTEINE; TRIFLUPROMAZINE; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; CANCER CELL; CELL DEATH; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME SEGREGATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPLICATION; DRUG TARGETING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INTERPHASE; MITOSIS; MITOSIS INHIBITION; MITOSIS SPINDLE; SENESCENCE;

EID: 70349270650     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.18.9623     Document Type: Article

References (59)

1. Nicklas RB, Ward SC, Gorbsky GJ. Kinetochore chemistry is sensitive to tension and may link mitotic forces to a cell cycle checkpoint. J Cell Biol 1995; 130:929-939
2. O'Connell CB, Khodjakov AL. Cooperative mechanisms of mitotic spindle formation. J Cell Sci 2007; 120:1717-1722
3. Rieder CL, Schultz A, Cole R, Sluder G. Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle. J Cell Biol 1994; 127:1301-1310 (Pubitemid 24362564)
4. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007; 8:379-393
5. Kelling J, Sullivan K, Wilson L, Jordan MA. Suppression of centromere dynamics by Taxol in living osteosarcoma cells. Cancer Res 2003; 63:2794-2801 (Pubitemid 36667150)
6. Jordan MA, Thrower D, Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 1991; 51:2212-2222
7. Andreassen PR, Martineau SN, Margolis RL. Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. Mutat Res 1996; 372:181-194
8. To-Ho KW, Cheung HW, Ling MT, Wong YC, Wang X. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells. Oncogene 2008; 27:347-357
9. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396:580-584 (Pubitemid 28563719)
10. 2/M phase contributes to survival during mitotic cell cycle arrest. Biochem J 2006; 399:335-342
11. Prescott DM. Cellular sites of RNA synthesis. Prog Nucleic Acid Res Mol Biol 1964; 3:33-57.
12. Blagosklonny MV. Mitotic arrest and cell fate: why and how mitotic inhibition of transcription drives mutually exclusive events. Cell Cycle 2007; 6:70-74
13. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996; 56:816-825 (Pubitemid 26055472)
14. Bhalla KN. Microtubule-targeted anticancer agents and apoptosis. Oncogene 2003; 22:9075-9086
15. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 2000; 97:13103-13107 (Pubitemid 30146205)
16. Rudner AD, Murray AW. The spindle assembly checkpoint. Curr Opin Cell Biol 1996; 8:773-780
17. Andreassen PR, Margolis RL. Induction of partial mitosis in BHK cells by 2-aminopurine. J Cell Sci 1991; 100:299-310.
18. Weaver BA, Cleveland DW. Decoding the links between mitosis, cancer and chemotherapy: The mitotic checkpoint, adaptation and cell death. Cancer Cell 2005; 8:7-12.
19. Elhajouji A, Cunha M, Kirsch-Volders M. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis 1998; 13:193-198 (Pubitemid 28138305)
20. Meek DW. The role of p53 in the response to mitotic spindle damage. Pathol Biol 2000; 48:246-254 (Pubitemid 30318125)
21. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005; 437:1043-1047 (Pubitemid 41486987)
22. Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007; 17:157-162
23. Senovilla L, Vitale I, Galluzzi L, Vivet S, Joza N, Younes AB, et al. p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis. Cell Cycle 2009; 8:1380-1385
24. Anderson HJ, de Jong G, Vincent I, Roberge M. Flow cytometry of mitotic cells. Exp Cell Res 1998; 238:498-502.
25. Zaman GJ. Cell-based screening. Drug Discov Today 2004; 9:828-830
26. Milstein S, Vidal M. Perturbing interactions. Nat Methods 2005; 2:412-414
27. Schriemer DC, Kemmer D, Roberge M. Design of phenotypic screens for bioactive chemicals and identification of their targets by genetic and proteomic approaches. Comb Chem High Throughput Screen 2008; 11:610-616
28. DeMoe JH, Santaguida S, Daum JR, Musacchio A, Gorbsky GJ. A high throughput, whole cell screen for small molecule inhibitors of the mitotic spindle checkpoint identifies OM137, a novel Aurora kinase inhibitor. Cancer Res 2009; 69:1509-1516
29. Salmela AL, Pouwels J, Varis A, Kukkonen AM, Toivonen P, Halonen PK, et al. Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint. Carcinogenesis 2009; 30:1032-1040
30. Ditchfield C, Johnson VL, Tighe A, Ellston R, Haworth C, Johnson T, et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2 and Cenp-E to kinetochores. J Cell Biol 2003; 161:267-280 (Pubitemid 36529846)
31. Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, et al. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol 2000; 20:9018-9027 (Pubitemid 32245931)
32. Dai Y, Dent P, Grant S. Induction of apoptosis in human leukemia cells by the CDK1 inhibitor CGP74514A. Cell Cycle 2002; 1:143-152
33. Andreassi C, Jarecki J, Zhou J, Coovert DD, Monani UR, Chen X, et al. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 2001; 10:2841-2849 (Pubitemid 34026465)
34. Tsuiki H, Nitta M, Tada M, Inagaki M, Ushio Y, Saya H. Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines. Oncogene 2001; 20:420-429 (Pubitemid 32158222)
35. Rudner AD, Hardwick KG, Murray AW. Cdc28 activates exit from mitosis in budding yeast. J Cell Biol 2000; 149:1361-1376 (Pubitemid 30437612)
36. Wheatley SP, Hinchcliffe EH, Glotzer M, Hyman AA, Sluder G, Wang Y. CDK1 inactivation regulates anaphase spindle dynamics and cytokinesis in vivo. J Cell Biol 1997; 138:385-393 (Pubitemid 27323540)
37. Wasch R, Cross FR. APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit. Nature 2002; 418:556-562 (Pubitemid 34851404)
38. Badie C, Itzhaki JE, Sullivan MJ, Carpenter AJ, Porter AC. Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells. Mol Cell Biol 2000; 20:2358-2366
39. 2 and mitosis. Cytometry 1998; 32:71-77
40. Karlsson MO, Molnar V, Freijs A, Nygren P, Bergh J, Larsson R. Pharmacokinetic models for the saturable distribution of paclitaxel. Drug Metab Dispos 1999; 27:1220-1223 (Pubitemid 29463611)
41. Brouwer E, Verweij J, De Bruijn P, Loos WJ, Pillay M, Buijs D, et al. Measurement of fraction unbound paclitaxel in human plasma. Drug Metab Dispos 2000; 28:1141-1145 (Pubitemid 30747319)
42. Veltkamp SA, Thijssen B, Garrigue JS, Lambert G, Lallemand F, Binlich F, et al. A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer. Br J Cancer 2006; 95:729-734 (Pubitemid 44373489)
43. Brito DA, Rieder CL. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol 2006; 16:1194-1200
44. Orth JD, Tang Y, Shi J, Loy CT, Amendt C, Wilm C, et al. Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate. Mol Cancer Ther 2008; 7:3480-3489
45. Demidenko ZN, Blagosklonny MV. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 2008; 7:3355-3361
46. Gascoigne KE, Taylor SS. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008; 14:111-122
47. Stolz A, Vogel C, Schneider V, Ertych N, Kienitz A, Yu H, et al. Pharmacologic abrogation of the mitotic spindle checkpoint by an indolocarbazole discovered by cellular screening efficiently kills cancer cells. Cancer Res 2009; 69:3874-3883
48. York DH. Dopamine receptor blockade - a central action of chlorpromazine on striatal neurones. Brain Res 1972; 37:91-99
49. Boder GB, Paul DC, Williams DC. Chlorpromazine inhibits mitosis of mammalian cells. Eur J Cell Biol 1983; 31:349-353
50. Lee MS, Johansen L, Zhang Y, Wilson A, Keegan M, Avery W, et al. The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action. Cancer Res 2007; 67:11359-11367 (Pubitemid 350248563)
51. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989; 246:629-634
52. Bain J, McLauchlan H, Elliott M, Cohen P. The specificities of protein kinase inhibitors: an update. Biochem J 2003; 371:199-204. (Pubitemid 36458094)
53. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J 2007; 408:297-315.
54. Chen JG, Yang CP, Cammer M, Horwitz SB. Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res 2003; 63:7891-7899 (Pubitemid 37466724)
55. Gabrielli B, Chau YQ, Giles N, Harding A, Stevens F, Beamish H. Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells. J Biol Chem 2007; 282:6954-6964 (Pubitemid 47093704)
56. 2-induced premature senescence. Cytometry A 2008; 73:808-815
57. Chan YW, Ma HT, Wong W, Ho CC, On KF, Poon RY. CDK1 inhibitors antagonize the immediate apoptosis triggered by spindle disruption but promote apoptosis following the subsequent rereplication and abnormal mitosis. Cell Cycle 2008; 7:1449-1461
58. Tao W, South VJ, Diehl RE, Davide JP, Sepp-Lorenzino L, Fraley ME, et al. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis. Mol Cell Biol 2007; 27:689-698 (Pubitemid 46080134)
59. Tao W, South VJ, Zhang Y, Davide JP, Farrell L, Kohl NE, et al. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell 2005; 8:49-59. (Pubitemid 40991814)